News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Actelion Ltd. (ALIOF.PK) Sale Possible If New Drug Fails



6/13/2011 7:55:07 AM

Actelion (ATLN.VX) could consider putting itself up for sale if key drug macitentan fails, an executive was quoted as saying on Sunday after the firm rebuffed the same demand from activist investor Elliott. "Should macitentan not be successful then all strategic options are possible, up to and including a sale," Roland Haefeli, Actelion head of investor relations, told Der Sonntag newspaper.

Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES